B

Belluscura PLC
LSE:BELL

Watchlist Manager
Belluscura PLC
LSE:BELL
Watchlist
Price: 10.25 GBX 7.89% Market Closed
Market Cap: 17.3m GBX
Have any thoughts about
Belluscura PLC?
Write Note
BELL
/
Income Statement
/
Interest Income Expense

Belluscura PLC
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Belluscura PLC
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
B
Belluscura PLC
LSE:BELL
Interest Income Expense
-$3.2m
CAGR 3-Years
-364%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Smith & Nephew PLC
LSE:SN
Interest Income Expense
-$127m
CAGR 3-Years
-72%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Interest Income Expense
-$54.3m
CAGR 3-Years
2%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
EKF Diagnostics Holdings PLC
LSE:EKF
Interest Income Expense
-£4k
CAGR 3-Years
85%
CAGR 5-Years
39%
CAGR 10-Years
46%
Angle PLC
LSE:AGL
Interest Income Expense
£152k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Creo Medical Group PLC
LSE:CREO
Interest Income Expense
£0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Belluscura PLC
Glance View

Market Cap
16.3m GBX
Industry
Health Care

Belluscura Plc engages in the provision of medical devices. The Company’s product, the X-PLO2R, is a lightweight portable oxygen concentrator (POC), which is designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The company focuses on devices and treatments involving oxygen. The X-PLO2R DX is designed to produce approximately six-liters pulse dose oxygen and approximately two-liters of flow oxygen. The firm is focused on developing the medical devices for treating people who are suffering from chronic lung diseases, such as the chronic obstructive pulmonary disease (COPD), respiratory distress caused by coronavirus disease (COVID-19), and other respiratory disorders.

BELL Intrinsic Value
11.52 GBX
Undervaluation 11%
Intrinsic Value
Price
B
What is Intrinsic Value?

See Also

What is Belluscura PLC's Interest Income Expense?
Interest Income Expense
-3.2m USD

Based on the financial report for Dec 31, 2023, Belluscura PLC's Interest Income Expense amounts to -3.2m USD.

What is Belluscura PLC's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
-364%

The average annual Interest Income Expense growth rates for Belluscura PLC have been -364% over the past three years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.